Use of Tranexamic Acid After Vaginal Delivery With Episiotomy a RCT Placebo Control Trail

• Status: Not yet recruiting
• Trial end date: 2024-07-10
• Target enrollment: 0
• Participant gender: Female

Summary

The objective of this study is to assess the effect of TA treatment on decline in Hb levels following vaginal delivery with an episiotomy, compared to a control group not receiving TA.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Assuta Ashdod Hospital
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

1. women aged 18-45

2. 37-42 weeks gestation

3. Singleton pregnancy

4. Cephalic presentation

Exclusion Criteria:

1. Any contra-indication for vaginal birth

2. PPH risk factors

1. Dysfunctional labor

2. Over distended uterus (macrosomia ,Polyhydramnios,multiple gestation)

3. Grand multiparity

4. Chorioamnionitis

5. Precipitous labor

6. Operative delivery

7. Prolonged second stage

3. Previous pph

4. Preeclampsia

5. Placental abruption

6. Previous cesarean delivery

7. Thrombophilia or coagulopathy

8. Allergy to TA